1-7 of 7
Abby Statler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Are Racial Disparities in Acute Myeloid Leukemia (AML) Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?

Abby Statler, PhD MPH, Brian P. Hobbs, PhD, Tomas Radivoyevitch, PhD, Sudipto Mukherjee, MD PhD MPH, Kimberly Bell, MBA, RN, BSN, Anjali S. Advani, MD, Aaron T. Gerds, MD MS, Aziz Nazha, MD, Bhumika J. Patel, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 381.
https://doi.org/10.1182/blood-2019-129096
Published: 2019
Journal Articles

Determinants of "Fitness" for Intensive Therapy Among Acute Myeloid Leukemia (AML) Patients

Abby Statler, PhDMPH, Brian P. Hobbs, PhD, Tomas Radivoyevitch, PhD, Caitlin Siebenaller, PharmD, Sudipto Mukherjee, MD PhD MPH, Anjali S. Advani, MD, Aaron T. Gerds, MD MS, Aziz Nazha, MD, Bhumika J. Patel, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3836.
https://doi.org/10.1182/blood-2019-128853
Published: 2019
Journal Articles

The Impact of Comorbidities and Organ Dysfunction Commonly Used for Clinical Trial Eligibility Criteria on Outcome in Acute Myeloid Leukemia (AML) Patients Receiving Induction Chemotherapy

Abby Statler, PhDMPH, Brian P. Hobbs, PhD, Tomas Radivoyevitch, PhD, Caitlin Siebenaller, PharmD, Sudipto Mukherjee, MD PhD MPH, Anjali S. Advani, MD, Aaron T. Gerds, MD MS, Aziz Nazha, MD, Bhumika J. Patel, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 16.
https://doi.org/10.1182/blood-2019-130319
Published: 2019
Journal Articles

Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies

Clinical Trials & Observations
Abby Statler, Megan Othus, Harry P. Erba, Thomas R. Chauncey, Jerald P. Radich, Steven Coutre, Anjali Advani, Sucha Nand, Farhad Ravandi, Sudipto Mukherjee, Mikkael A. Sekeres
Journal: Blood
Blood (2018) 131 (25): 2782–2788.
https://doi.org/10.1182/blood-2018-01-826693
Published: 2018
Includes: Supplemental data
Journal Articles

Clinical Trial Inclusion of Therapy-Related Myelodysplastic Syndromes (MDS) over the Past 20 Years

Uma Borate, MD, Brianna Norris, BS, Abby Statler, BA, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 4250.
https://doi.org/10.1182/blood.V130.Suppl_1.4250.4250
Published: 2017
Journal Articles

Comparable Outcomes of Patients Eligible Versus Ineligible for Southwest Oncology Group (SWOG) Leukemia Studies

Abby Statler, MPH, MA, Megan Othus, PhD, Harry P. Erba, MD PhD, Thomas R. Chauncey, MD PhD, Jerald P. Radich, MD, Steven E. Coutre, MD, Anjali S. Advani, MD, Sucha Nand, MD, Farhad Ravandi, MD, Sudipto Mukherjee, MD, PhD, M.P.H., Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2016) 128 (22): 4002.
https://doi.org/10.1182/blood.V128.22.4002.4002
Published: 2016
Journal Articles

Eligibility Criteria Are Not Associated with Expected or Observed Adverse Events in Randomized Controlled Trials (RCTs) of Hematologic Malignancies

Abby Statler, MPH, MA, Tomas Radivoyevitch, PhD, Caitlin Siebenaller, PharmD, BCOP, Aaron T. Gerds, MD MS, Matt Kalaycio, MD, Eric Kodish, MD, Sudipto Mukherjee, MD PhD, Connie Cheng, PharmD, BCOP, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2015) 126 (23): 635.
https://doi.org/10.1182/blood.V126.23.635.635
Published: 2015